Literature DB >> 11557028

Human L-type amino acid transporter 1 (LAT1): characterization of function and expression in tumor cell lines.

O Yanagida1, Y Kanai, A Chairoungdua, D K Kim, H Segawa, T Nii, S H Cha, H Matsuo, J Fukushima, Y Fukasawa, Y Tani, Y Taketani, H Uchino, J Y Kim, J Inatomi, I Okayasu, K Miyamoto, E Takeda, T Goya, H Endou.   

Abstract

System L is a major nutrient transport system responsible for the transport of large neutral amino acids including several essential amino acids. We previously identified a transporter (L-type amino acid transporter 1: LAT1) subserving system L in C6 rat glioma cells and demonstrated that LAT1 requires 4F2 heavy chain (4F2hc) for its functional expression. Since its oncofetal expression was suggested in the rat liver, it has been proposed that LAT1 plays a critical role in cell growth and proliferation. In the present study, we have examined the function of human LAT1 (hLAT1) and its expression in human tissues and tumor cell lines. When expressed in Xenopus oocytes with human 4F2hc (h4F2hc), hLAT1 transports large neutral amino acids with high affinity (K(m)= approximately 15- approximately 50 microM) and L-glutamine and L-asparagine with low affinity (K(m)= approximately 1.5- approximately 2 mM). hLAT1 also transports D-amino acids such as D-leucine and D-phenylalanine. In addition, we show that hLAT1 accepts an amino acid-related anti-cancer agent melphalan. When loaded intracellularly, L-leucine and L-glutamine but not L-alanine are effluxed by extracellular substrates, confirming that hLAT1 mediates an amino acid exchange. hLAT1 mRNA is highly expressed in the human fetal liver, bone marrow, placenta, testis and brain. We have found that, while all the tumor cell lines examined express hLAT1 messages, the expression of h4F2hc is varied particularly in leukemia cell lines. In Western blot analysis, hLAT1 and h4F2hc have been confirmed to be linked to each other via a disulfide bond in T24 human bladder carcinoma cells. Finally, in in vitro translation, we show that hLAT1 is not a glycosylated protein even though an N-glycosylation site has been predicted in its extracellular loop, consistent with the property of the classical 4F2 light chain. The properties of the hLAT1/h4F2hc complex would support the roles of this transporter in providing cells with essential amino acids for cell growth and cellular responses, and in distributing amino acid-related compounds.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11557028     DOI: 10.1016/s0005-2736(01)00384-4

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  201 in total

1.  Preclinical characterization of 18F-D-FPHCys, a new amino acid-based PET tracer.

Authors:  Delphine Denoyer; Laura Kirby; Kelly Waldeck; Peter Roselt; Oliver C Neels; Thomas Bourdier; Rachael Shepherd; Andrew Katsifis; Rodney J Hicks
Journal:  Eur J Nucl Med Mol Imaging       Date:  2011-12-13       Impact factor: 9.236

2.  LAT1 overexpression and function compensates downregulation of ASCT2 in an in vitro model of renal proximal tubule cell ageing.

Authors:  Maria João Pinho; José Miguel Cabral; Elisabete Silva; Maria Paula Serrão; Patrício Soares-da-Silva
Journal:  Mol Cell Biochem       Date:  2010-12-02       Impact factor: 3.396

3.  Clinical significance of coexpression of L-type amino acid transporter 1 (LAT1) and ASC amino acid transporter 2 (ASCT2) in lung adenocarcinoma.

Authors:  Tomohiro Yazawa; Kimihiro Shimizu; Kyoichi Kaira; Toshiteru Nagashima; Yoichi Ohtaki; Jun Atsumi; Kai Obayashi; Shushi Nagamori; Yoshikatsu Kanai; Tetsunari Oyama; Izumi Takeyoshi
Journal:  Am J Transl Res       Date:  2015-06-15       Impact factor: 4.060

4.  Prognostic significance of L-type amino acid transporter 1 (LAT1) expression in patients with ovarian tumors.

Authors:  Kyoichi Kaira; Kazuto Nakamura; Takashi Hirakawa; Hisao Imai; Hideyuki Tominaga; Noboru Oriuchi; Shushi Nagamori; Yoshikatsu Kanai; Norifumi Tsukamoto; Tetsunari Oyama; Takayuki Asao; Takashi Minegishi
Journal:  Am J Transl Res       Date:  2015-06-15       Impact factor: 4.060

5.  (1)H-NMR-based metabolomics of tumor tissue for the metabolic characterization of rat hepatocellular carcinoma formation and metastasis.

Authors:  Juan Wang; Shu Zhang; Zongfang Li; Jun Yang; Chen Huang; Rongrui Liang; Zhongwei Liu; Rui Zhou
Journal:  Tumour Biol       Date:  2010-10-04

6.  Regulation of Amino Acid Transporters and Sensors in Response to a High protein Diet: A Randomized Controlled Trial in Elderly Men.

Authors:  N Zeng; U Prodhan; R F D'Souza; F Ramzan; S M Mitchell; P Sharma; S O Knowles; N C Roy; A Sjödin; K-H Wagner; A M Milan; D Cameron-Smith; C J Mitchell
Journal:  J Nutr Health Aging       Date:  2019       Impact factor: 4.075

Review 7.  The role of CD98 in astrocytic neoplasms.

Authors:  Hiroshi Nawashiro; Naoki Otani; Nariyoshi Shinomiya; Shinji Fukui; Namiko Nomura; Akiko Yano; Katsuji Shima; Hirotaka Matsuo; Yoshikatsu Kanai
Journal:  Hum Cell       Date:  2002-03       Impact factor: 4.174

8.  L-type amino-acid transporter 1 (LAT1): a therapeutic target supporting growth and survival of T-cell lymphoblastic lymphoma/T-cell acute lymphoblastic leukemia.

Authors:  C Rosilio; M Nebout; V Imbert; E Griessinger; Z Neffati; J Benadiba; T Hagenbeek; H Spits; J Reverso; D Ambrosetti; J-F Michiels; B Bailly-Maitre; H Endou; M F Wempe; J-F Peyron
Journal:  Leukemia       Date:  2014-12-08       Impact factor: 11.528

9.  Structure and mechanism of a Na+-independent amino acid transporter.

Authors:  Paul L Shaffer; April Goehring; Aruna Shankaranarayanan; Eric Gouaux
Journal:  Science       Date:  2009-07-16       Impact factor: 47.728

10.  LAT1 activity of carboxylic acid bioisosteres: Evaluation of hydroxamic acids as substrates.

Authors:  Arik A Zur; Huan-Chieh Chien; Evan Augustyn; Andrew Flint; Nathan Heeren; Karissa Finke; Christopher Hernandez; Logan Hansen; Sydney Miller; Lawrence Lin; Kathleen M Giacomini; Claire Colas; Avner Schlessinger; Allen A Thomas
Journal:  Bioorg Med Chem Lett       Date:  2016-09-03       Impact factor: 2.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.